Published in:
Open Access
01-12-2012 | Research
Identification of B cell epitopes reactive to human papillomavirus type-16L1- derived peptides
Authors:
Akimasa Fukui, Satoko Matsueda, Kouichiro Kawano, Naotake Tsuda, Nobukazu Komatsu, Shigeki Shichijo, Tetsuro Sasada, Satoshi Hattori, Kimio Ushijima, Kyogo Itoh, Toshiharu Kamura
Published in:
Virology Journal
|
Issue 1/2012
Login to get access
Abstract
Background
Persistent infection of human papillomavirus (HPV) types 16 and 18 causes cervical cancer. To better understand immune responses to the prophylactic vaccine, HPV 16/18 L1 virus-like particles (HPV-VLPs), we investigated B cell epitopes of HPV16 L1-derived peptides.
Methods
Sera from mice immunized with HPV-16/18 L1 VLPs were analyzed for their IgG titers against 10 different HPV16 L1-derived peptides (20-mer) that contain human leukocyte antigen (HLA)-class I A-2, A-24 and class II DR.
Results
One 20-mer peptide at positions 300 to 319 was identified as a common B cell epitope in both Balb/c (H-2d) and C57BL/6 (H-2b) mice. Mapping analysis showed that the 10-amino-acid sequence at positions 304to 313 was an immunogenic portion. It is of note that the binding capability of this 10-mer peptide to the HLA-A2 and HLA-A24 molecules was confirmed by the HLA class I stabilization assay. In addition, one unique 20-mer was determined as a B cell epitope in each strain.
Conclusions
These results might provide new information for better understanding of immune responses to HPV 16 L1.